Background
==========

Microglial cells are resident macrophages of the nervous system with pivotal roles in innate immune regulation and neuronal homeostasis \[[@B1],[@B2]\]. They are cells of the mononuclear phagocyte lineage but their unique localization within the nervous system and their morphological features clearly distinguish them from other macrophage populations \[[@B3]\]. Ramified microglial cells actively scan their environment with their long protrusions \[[@B4],[@B5]\] and continuous inhibitory signals from neurons prevent microglial toxicity \[[@B6],[@B7]\]. Disconnection of the microglia-neuron cross-talk \[[@B8]\], local danger signals such as released ATP \[[@B9]\], or neurotransmitter gradients \[[@B10]\] can lead to a functional transformation of microglial populations with a variety of effector functions. Consequently, alarmed microglia and reactive microgliosis have been identified in a variety of neurodegenerative diseases including Alzheimer\'s disease \[[@B11]\], Parkinson\'s disease \[[@B12]\], amyotrophic lateral sclerosis \[[@B13]\], multiple sclerosis \[[@B14]\], and inherited photoreceptor dystrophies \[[@B15]\]. The concept of a microglia-targeted pharmacotherapy to prevent neurodegeneration in the brain and the retina is therefore a promising approach under active investigation \[[@B16],[@B17]\].

There is a growing interest in the identification of natural compounds that limit neuroinflammation and simultaneously support neuronal survival \[[@B18],[@B19]\]. Among the naturally occuring immuno-modulators, curcumin ((E, E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione), a major constituent of tumeric, is a herbal medicine used for centuries in India and China \[[@B20]\]. Curcumin has a wide range of pharmacological activities including anti-inflammatory, anti-microbial, antioxidant, and anti-tumor effects \[[@B21]\]. Curcumin is a particularly potent immuno-regulatory agent that can modulate the activation and function of T-cells, B-cells, neutrophils, natural killer cells and macrophages \[[@B22]\].

Curcumin treatment effectively inhibits the activation of microglial cells by diminishing the production of nitric oxide \[[@B23]\] and reducing the secretion of pro-inflammatory cytokines such as IL1β, IL6 and TNF \[[@B24]\]. Moreover, curcumin blocks the LPS-mediated induction of cyclooxygenase-2 (COX2) via inhibition of the transcription factors nuclear factor kappa B (NFkB), activator protein 1 (AP1), and signal transducers and activators of transcription (STATs) \[[@B25],[@B26]\]. Recent experiments have also demonstrated that curcumin protects dopaminergic neurons against microglia-mediated neurotoxicity \[[@B27]\], limits brain inflammation \[[@B28]\], and rescues retinal cells from stress-induced cell death \[[@B29]\].

The inhibitory role of curcumin on pro-inflammatory gene expression in microglia is well documented. However, this information is limited to only a few well-studied examples including pro-inflammatory cytokines, Nos2 and COX2. In a genome-wide search for target genes, we investigated the transcriptomic effects of curcumin in resting and LPS-activated BV-2 microglial cultures using DNA-microarrays. Furthermore, we validated the curcumin-regulated expression of microglial transcripts with qRT-PCR and studied the related microglial migration and neurotoxicity.

Methods
=======

Reagents
--------

Curcumin and *E.coli*0111:B4 lipopolysaccharide were purchased from Sigma Aldrich (Steinheim, Germany). Curcumin was dissolved in DMSO and added in concentrations that did not exceed 0.05% of the total volume in any of the cell culture experiments.

Cell culture
------------

BV-2 microglia-like cells were provided by Professor Ralph Lucius (Clinic of Neurology, Christian Albrechts University, Kiel, Germany). BV-2 cells were cultured in RPMI/5% FCS supplemented with 2 mM L-Glutamine and 195 nM β-mercaptoethanol. BV-2 cells were stimulated with 100 ng/ml LPS, 20 μM of curcumin, or DMSO as control for 6 h. These stimulation conditions were adapted from previously published experiments \[[@B24],[@B30]\]. MTT assays revealed that 100 ng/ml LPS, 20 μM curcumin, or a combination of both had no cytotoxic effects on BV-2 cells (data not shown). 661W photoreceptor-like cells were a gift from Prof. Muayyad Al-Ubaidi (University of Illinois, Chicago, IL) and the culture conditions have been described elsewhere \[[@B31]\].

Scratch assay
-------------

500.000 BV-2 cells were grown in 6-well plates as 80% confluent monolayers and were wounded with a sterile 100 μl pipette tip. Thereafter, the cells were stimulated with 100 ng/ml LPS, 20 μM of curcumin, 100 ng/ml LPS + 20 μM of curcumin, or DMSO as solvent control. Migration into the open scar was documented with microphotographs at different time points after wounding. The number of migrating cells was quantified by counting all cells within a 0.4 mm^2^region in the center of each scratch. A minimum of 5 individual cultures was used to calculate the mean migratory capacity of each cell culture condition.

Transwell migration assay
-------------------------

The Costar Transwell System (8-μm pore size polycarbonate membrane) was used to evaluate vertical cell migration. 1 Mio BV-2 cells in 1.5 ml serum-free medium were added to the upper well, and 2.6 ml serum-free medium was added to the lower chamber. 100 ng/ml LPS, 20 μm curcumin, 100 ng/ml LPS + 20 μm curcumin, or DMSO as solvent control were added to the lower chamber medium. At the end of a 24 h incubation period, cells that had migrated to the lower surface were quantified by counting the migrated cells on the lower surface of the membrane using microscopy.

661W co-culture in microglia-conditioned medium and apoptosis assay
-------------------------------------------------------------------

To test microglial neurotoxicity, a culture system of 661W photoreceptors with microglia conditioned medium was established. 661W cells were incubated for 48 h either in their own medium or with culture supernatants from unstimulated, 100 ng/ml LPS, 20 μM curcumin, or 100 ng/ml LPS + 20 μM curcumin treated microglial cells. The 661W cell morphology was assessed by phase contrast microscopy and apoptotic cell death was determined with the Caspase-Glo^®^3/7 Assay (Promega). Cells were lysed and incubated with a luminogenic caspase-3/7 substrate, which contains the tetrapeptide sequence DEVD. Luminescence was then generated by addition of recombinant luciferase and was proportional to the amount of caspase activity present. The luminescent signal was read on a BMG FluoStar Optima plate reader (Labtech, Offenburg, Germany). A blank reaction was used to measure background luminescence associated with the cell culture system and Caspase-Glo^®^3/7 Reagent. The value for the blank reaction was subtracted from all experimental values. Negative control reactions were performed to determine the basal caspase activity of 661W cells. Relative luciferase units (RLU) reflect the level of apoptotic cell death in the different 661W cell cultures.

RNA isolation and reverse transcription
---------------------------------------

Total RNA was extracted from cultured microglial cells according to the manufacturer\'s instructions using the RNeasy Protect Mini Kit (Qiagen, Hilden, Germany). Purity and integrity of the RNA was assessed on the Agilent 2100 bioanalyzer with the RNA 6000 Nano LabChip^®^reagent set (Agilent Technologies, Böblingen, Germany). The RNA was quantified spectrophotometrically and then stored at -80°C. First-strand cDNA synthesis was performed with RevertAid™ H Minus First Strand cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany).

DNA-microarray analysis
-----------------------

4 × 44 K microarrays (014868) (Agilent Technologies) were used for hybridization with three independent RNAs from non-stimulated BV-2 microglial cells or cultures treated for 6 h with 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS, respectively. Briefly, 200 ng of total RNA were labeled with Cy3 using the Agilent Quick-Amp Labeling Kit - 1 color according to the manufacturer\'s instructions. cRNA was purified with the RNeasy Mini Kit (Qiagen) and labeling efficiency was determined with a NanoDrop ND-1000 photometer (PeqLab). The arrays were incubated with cRNAs in Agilent SureHyb chambers for 17 hours at 65°C while rotating. After washing, scanning was done with the Agilent G2565CA Microarray Scanner System and the resulting TIFF files were processed with Agilent Feature Extraction software (10.7.). Minimum information about a microarray experiment (MIAME) criteria were met \[[@B32]\]. The microarray dataset of this study is publicly available at the National Center for Biotechnology Information Gene Expression Omnibus <http://www.ncbi.nlm.nih.gov/geo/> as series record GSE23639.

Bioinformatic data analysis
---------------------------

Integrative analysis of genome-wide expression activities from BV-2 cells was performed with the Gene Expression Dynamics Inspector (GEDI), a Matlab (Mathworks, Natick, MA) freeware program which uses self-organizing maps (SOMs) to translate high-dimensional data into a 2D mosaic \[[@B33]\]. Each tile of the mosaic represents an individual SOM cluster and is color-coded to represent high or low expression of the cluster\'s genes, thus identifying the underlying pattern. The Partek Genomics Suite (Partek Inc.) was used for ANOVA analysis and hierarchical clustering of normalized expression values. Differentially regulated transcrips in curcumin-stimulated versus non-treated and curcumin + LPS versus LPS-treated BV-2 cells, respectively, were retrieved with the Genomatix ChipInspector program (Genomatix Software GmbH, Munich, Germany), applying the Significance Analysis of Microarray (SAM) algorithm using a false-discovery rate of 0.1%.

Quantitative real-time RT-PCR
-----------------------------

Amplifications of 50 ng cDNA were performed with an ABI7900HT machine (Applied Biosystems) in triplicates in 10 μl reaction mixtures containing 1×TaqMan Universal PCR Master Mix (Applied Biosystems), 200 nM of primers and 0.25 μl dual-labeled probe (Roche ProbeLibrary). The reaction parameters were as follows: 2-min 50°C hold, 30-min 60°C hold, and 5-min 95°C hold, followed by 45 cycles of 20-s 94°C melt and 1-min 60°C anneal/extension. Measurements were performed in triplicate. Results were analyzed with an ABI sequence detector software version 2.3 using the ΔΔCt method for relative quantitation. A Ct (cycle threshold) \< 35 was used as cutoff for estimating significantly expressed transcripts and cDNA samples with values \> 35 were marked with n.e. for [n]{.ul}ot [e]{.ul}xpressed. Ct-values between 35 and 40 were solely used for calculation of relative expression differences in treated cells versus control cells. Primer sequences and Roche Library Probe numbers are listed in Table [1](#T1){ref-type="table"}.

###### 

Primer pairs and Roche library probes for real-time qRT-PCR validation

  Gene       F-Primer (5\'-3\')         R-Primer (5\'-3\')            Roche Library Probe
  ---------- -------------------------- ----------------------------- ---------------------
  *Atp5b*    ggcacaatgcaggaaagg         tcagcaggcacatagatagcc         77
  *C3*       accttacctcggcaagtttct      ttgtagagctgctggtcagg          76
  *Ccl2*     catccacgtgttggctca         gatcatcttgctggtgaatgagt       62
  *Dll1*     ttcaactgtgagaagaagatggat   gccgaggtccacacactt            103
  *Egr2*     ctacccggtggaagacctc        aatgttgatcatgccatctcc         60
  *Il4*      catcggcattttgaacgag        cgagctcactctctgtggtg          2
  *Il6*      gatggatgctaccaaactggat     ccaggtagctatggtactccaga       6
  *Nos2*     ctttgccacggacgagac         tcattgtactctgagggctga         13
  *Ntng1*    aggggcaagagaccaagg         agggatggtgtctatcgtcct         103
  *Pecam1*   cggtgttcagcgagatcc         cgacaggatggaaatcacaa          45
  *Perp1*    tcatatgccggctcacct         atccactggcgtctggagt           110
  *Pparα*    ccgagggctctgtcatca         gggcagctgactgaggaa            11
  *Ptgs2*    gatgctcttccgagctgtg        ggattggaacagcaaggattt         45
  *Stat1*    aaatgtgaaggatcaagtcatgtg   catcttgtaattcttctagggtcttga   15
  *Tlr2*     accgaaacctcagacaaagc       cagcgtttgctgaagagga           49

Statistical analyses
--------------------

Statistical analyses were performed on ΔΔCt data using the Mann-Whitney Rank Sum test and quantitative expression data are expressed as mean ± SD plotted at a logarithmic scale. Gene expression levels in control BV-2 cells were used as calibrators. The Student\'s t test or Mann-Whitney Rank Sum test were used for the comparison of experimental groups in cell migration assays and apoptosis assays as indicated. p \< 0.05 was considered significant.

Results
=======

Curcumin has a major impact on the microglial transcriptome
-----------------------------------------------------------

To determine the transcriptional profiles of resting and LPS-activated BV-2 microglial cells after treatment with 20 μM curcumin for 6 h, we performed DNA-microarray analyses from three independent stimulations. We first applied the Gene Expression Dynamics Inspector (GEDI) on the complete dataset to visualize the global patterns of gene expression in the four different conditions, untreated, curcumin-treated, LPS-treated, and curcumin + LPS-treated cells. GEDI uses self-organizing maps to capture genome-wide transcriptome activity via \'gestalt\' recognition \[[@B33]\]. GEDI facilitates the identification of genome-wide patterns with each mosaic tile in the map representing a gene cluster that is expressed at similar levels. The four GEDI maps, with blue color indicating low and red color high mRNA expression levels, show a dynamic regulation of gene transcription in the cultured microglial cells (Figure [1A](#F1){ref-type="fig"}). The major difference between curcumin-treated resting microglial cells and control cells was a region with higher expression at the bottom of the map (Figure [1A](#F1){ref-type="fig"}, white rectangles). In the LPS-treated condition, mimicking a highly activated state, curcumin elicited a largely converse expression pattern with a pronounced area of weakly expressed genes (Figure [1A](#F1){ref-type="fig"}, white circles). These data indicate that curcumin stimulates gene expression in resting, non-activated cells but mainly dampens activation-associated transcriptional programs in LPS-primed microglia.

![**Curcumin influences global gene expression in resting and LPS-activated BV-2 microglial cells**. (A) Gene Expression Dynamics Inspector (GEDI) analysis of the complete DNA-microarray dataset from control BV-2 cells or cells treated with 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS for 6 hours. The white rectangles and circles denote the most prominent expression changes in corresponding gene clusters. (B) Hierarchical clustering of normalized expression levels after one-way ANOVA at p \< 0.01. Triplicate microarrays were analyzed for each condition and the pseudo-color scale indicates high (red) or low (blue) expression levels. LPS and curcumin-related clusters are marked with A and B, respectively.](1742-2094-8-125-1){#F1}

We next calculated hierarchical clusters of each individual microarray dataset after filtering for significantly altered gene expression using one way ANOVA at p \< 0.01. This analysis showed a clear separation of the four different conditions with their own characteristic gene expression profiles (Figure [1B](#F1){ref-type="fig"}). The clustering revealed two distinct groups of inversely regulated genes. Group A (Figure [1B](#F1){ref-type="fig"}) contains LPS-induced genes, which are no longer up-regulated in the presence of curcumin. Group B (Figure [1B](#F1){ref-type="fig"}) represents genes selectively up-regulated by curcumin treatment of resting microglial cells. Together with the GEDI analysis, these results demonstrate that stimulation with curcumin impacts distinct patterns of gene expression in resting and LPS-activated microglial cells, respectively.

To narrow down the identified global gene clusters to a subset of genes with significantly different mRNA expression in the different curcumin-treated conditions, we used the Genomatix ChipInspector tool applying the Significance Analysis of Microarray (SAM) algorithm at a false discovery rate of 0.1% and a minimum fold change of 2.0 \[[@B34]\]. Thereby, 35 significantly regulated transcripts were identified in curcumin-treated versus resting microglial cells (Table [2](#T2){ref-type="table"}) and 30 differentially expressed genes were detected in curcumin + LPS versus LPS-stimulated cells (Table [3](#T3){ref-type="table"}). Comparison of the total numer of differentially expressed transcripts and considering overlapping gene sets revealed that curcumin affects both resting and LPS-activated BV-2 cells.

###### 

Differentially expressed transcripts after 6 h stimulation of BV-2 cells with 20 μM curcumin

  Nr                   ID       Symbol   Gene Name                                          FC
  -------------------- -------- -------- -------------------------------------------------- -------
  **UP-REGULATED**                                                                          
  1                    80883    Ntng1    Netrin G1                                          313.0
  2                    18613    Pecam1   Platelet/endothelial cell adhesion molecule 1      42.8
  3                    13388    Dll1     Delta-like 1                                       35.5
  4                    12824    Col2a1   Collagen, type II, alpha 1                         21.6
  5                    14103    Fasl     Fas ligand (TNF superfamily, member 6)             12.8
  6                    12653    Chgb     Chromogranin B                                     11.9
  7                    66184    Rps4y2   Ribosomal protein S4, Y-linked 2                   9.7
  8                    69816    Perp1    RIKEN cDNA 2010001M09 gene                         9.7
  9                    16992    Lta      Lymphotoxin A                                      9.4
  10                   19206    Ptch1    Patched homolog 1                                  5.9
  11                   19013    Ppara    Peroxisome proliferator activated receptor alpha   4.6
  12                   109685   Hyal3    Hyaluronoglucosaminidase 3                         4.5
  13                   20997    T        Brachyuri                                          4.2
  14                   17246    Mdm2     Transformed mouse 3T3 cell double minute 2         3.1
  15                   14102    Fas      Fas                                                2.8
  16                   14183    Fgfr2    Fibroblast growth factor receptor 2                2.7
  17                   13645    Egf      Epidermal growth factor                            2.2
  18                   14179    Fgf8     Fibroblast growth factor 8                         2.1
  19                   20655    Sod1     Superoxide dismutase 1                             2.1
  20                   14526    Gcg      Glucagon                                           2.0
  **DOWN-REGULATED**                                                                        
  1                    24088    Tlr2     Toll-like receptor 2                               -6.9
  2                    18505    Pax3     Paired box gene 3                                  -6.6
  3                    14281    Fos      FBJ osteosarcoma oncogene                          -4.4
  4                    11622    Ahr      Aryl-hydrocarbon receptor                          -4.1
  5                    16835    Ldlr     Low density lipoprotein receptor                   -3.8
  6                    13654    Egr2     Early growth response 2                            -3.5
  7                    68010    Bambi    BMP and activin membrane-bound inhibitor           -3.3
  8                    12048    Bcl2l1   BCL2-like 1                                        -3.3
  9                    19225    Ptgs2    Prostaglandin-endoperoxide synthase 2              -3.0
  10                   20296    Ccl2     Chemokine (C-C motif) ligand 2                     -2.8
  11                   12393    Runx2    Runt related transcription factor 2                -2.8
  12                   17311    Kitl     Kit ligand                                         -2.4
  13                   16869    Lhx1     LIM homeobox protein 1                             -2.4
  14                   12977    Csf1     Colony stimulating factor 1                        -2.4
  15                   20528    Slc2a4   Solute carrier family 2, member 4                  -2.2

Significance analysis of triplicate microarrays was performed with a false discovery rate of 0.1%. ID, Entrez Gene ID; FC: Fold change.

###### 

Differentially expressed transcripts after 6 h stimulation with 20 μM curcumin + 100 ng/ml LPS versus 100 ng/ml LPS

  Nr                   ID       Symbol     Gene Name                                             FC
  -------------------- -------- ---------- ----------------------------------------------------- -------
  **UP-REGULATED**                                                                               
  1                    80883    Ntng1      Netrin G1                                             86.2
  2                    18613    Pecam1     Platelet/endothelial cell adhesion molecule 1         11.7
  3                    12824    Col2a1     Collagen, type II, alpha 1                            9.0
  4                    12653    Chgb       Chromogranin B                                        8.1
  5                    14103    Fasl       Fas ligand (TNF superfamily, member 6)                6.9
  6                    19206    Ptch1      Patched homolog 1                                     6.5
  7                    69816    Perp1      RIKEN cDNA 2010001M09 gene                            5.4
  8                    14526    Gcg        Glucagon                                              5.0
  9                    109685   Hyal3      Hyaluronoglucosaminidase 3                            4.1
  10                   16189    Il4        Interleukin 4                                         3.8
  11                   20655    Sod1       Superoxide dismutase 1                                3.5
  12                   19013    Ppara      Peroxisome proliferator activated receptor alpha      3.1
  13                   20997    T          Brachyuri                                             2.6
  14                   640627   Gm9789     ENSMUSG00000044227                                    2.6
  15                   16147    Ihh        Indian hedgehog homolog                               2.6
  16                   17246    Mdm2       Transformed mouse 3T3 cell double minute 2            2.5
  17                   99439    Duox1      Dual oxidase 1                                        2.3
  18                   257956   Olfr1307   Olfactory receptor 1307                               2.3
  19                   14179    Fgf8       Fibroblast growth factor 8                            2.1
  **DOWN-REGULATED**                                                                             
  1                    16193    Il6        Interleukin 6                                         -93.1
  2                    18126    Nos2       Nitric oxide synthase 2                               -55.7
  3                    19225    Ptgs2      Prostaglandin-endoperoxide synthase 2                 -17.6
  4                    20296    Ccl2       Chemokine (C-C motif) ligand 2                        -14.7
  5                    12266    C3         Complement C3                                         -9.1
  6                    20846    Stat1      Signal transducers and activator of transcription 1   -7.4
  7                    12048    Bcl2l1     BCL2-like 1                                           -5.4
  8                    14281    Fos        FBJ osteosarcoma oncogene                             -4.6
  9                    16835    Ldlr       Low density lipoprotein receptor                      -4.1
  10                   16992    Lta        Lymphotoxin A                                         -3.5
  11                   17395    Mmp9       Matrix metallopeptidase 9                             -2.2

Significance analysis of triplicate microarrays was performed with a false discovery rate of 0.1%. ID, Entrez Gene ID; FC: Fold change.

qRT-PCR confirmation of novel curcumin target genes in microglial cells
-----------------------------------------------------------------------

To validate selected differentially expressed genes identified by DNA-microarrays, real-time qRT-PCR assays were performed with RNA samples from three independent BV-2 stimulation series. We especially focused on genes which have not been previously shown to be curcumin targets. In the first set of experiments, mRNA levels of genes highly up-regulated by curcumin compared to control cells were assessed (Figure [2](#F2){ref-type="fig"}). Transcripts of Netrin G1 (*Ntng1*), Platelet endothelial cell adhesion molecule 1 (*Pecam1*), Delta-like 1 (*Dll1*), Plasma cell endoplasmic reticulum protein 1 (*Perp1*), Peroxisome proliferator activated receptor alpha (*PPARα*), and Interleukin 4 (*Il4*) were all significantly increased by stimulation with curcumin (Figure [2](#F2){ref-type="fig"}). *Ntng1*showed the strongest expression difference with a change of more than 1800-fold. *Perp1*and *PPARα*transcripts were not significantly expressed in resting microglia and were switched on to intermediate levels after curcumin treatment (Figure [2](#F2){ref-type="fig"}). All six transcripts after combined LPS/curcumin treatment remained similarly high as after curcumin stimulation alone, indicating that the effects of curcumin persist in activated microglial cells.

![**Curcumin induces genes related to adhesion and anti-inflammatory response**. Real-time qRT-PCR validation of transcripts in BV-2 microglia stimulated with 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS for 6 hours. Relative mRNA levels were quantified for Netrin G1 (*Ntng1*), Platelet endothelial call adhesion molecule 1 (*Pecam1*), Delta-like 1 (*Dll1*), Plasma cell induced endoplasmic reticulum protein 1 (*Perp1*), Peroxisome proliferator activated receptor α (*PPARα*), and Interleukin 4 (*Il4*). Expression was normalized to the control gene Atp5b and mRNA levels (+/- SD) are graphed relative to control cells. Results are calculated from three independent experiments performed in triplicate measurements. \* p ≤ 0.05, \*\*\* p ≤ 0.001 for curcumin vs. control, Mann-Whitney Rank Sum test. n.e., not expressed.](1742-2094-8-125-2){#F2}

In the next series of qRT-PCR experiments, down-regulated transcripts known to be involved in pro-inflammatory activation of microglial cells were analyzed. Toll-like receptor 2 (*Tlr2*), Early growth response 2 (*Egr2*), Prostaglandin endoperoxide synthase 2 (*Ptgs2*, alias *Cox2*), and Chemokine (C-C-motif) ligand 2 (*Ccl2*, alias *Mcp1*) showed diminished transcript levels in curcumin-treated resting BV-2 cells (Figure [3A](#F3){ref-type="fig"}). In the activated state, microglial cells also had the tendency to expressed lower amounts of these transcript but only *Ccl2*levels reached the level of statistical significance. When LPS-activated BV-2 cells were incubated in the presence of curcumin, transcription of Interleukin 6 (*Il6*), nitric oxide synthase 2 (*Nos2*, alias *iNos*), Signal transducer and activator of transcription 1 (*Stat1*), and Complement factor C3 (*C3*) were all repressed (Figure [3B](#F3){ref-type="fig"}).

![**Curcumin potently blocks pro-inflammatory gene expression**. Real-time qRT-PCR validation of transcripts in BV-2 microglia stimulated with 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS for 6 hours. Relative mRNA levels were quantified for (A) Toll-like receptor 2 (*Tlr2*), Early growth response 2 (*Egr2*), Prostaglandin endoperoxide synthase 2 (*Ptgs2*), Chemokine ligand 2 (*Ccl2*), and (B) Interleukin 6 (*Il6*), Nitric oxide synthase 2 (*Nos2*, alias *iNos*), Signal transducer and activator of transcription 1 (*Stat1*), Complement C3 (*C3*). Expression was normalized to the control gene Atp5b and mRNA levels (+/- SD) are graphed relative to control cells. Results are calculated from three independent experiments performed in triplicate measurements. \* p ≤ 0.05, \*\* p ≤ 0.01, \*\*\* p ≤ 0.001 for curcumin vs. control, and \# p ≤ 0.05, \#\# p ≤ 0.01 for curcumin + LPS vs. LPS, Mann-Whitney Rank Sum test.](1742-2094-8-125-3){#F3}

Curcumin has an inhibitory effect on microglial migration
---------------------------------------------------------

The induction of several transcripts related to cell motility and adhesion (*Ntng1*, *Pecam1*, and *Perp1*) prompted us to study the effect of curcumin on microglial migration. We first cultured BV-2 microglia on plastic dishes until 80% confluence and then created a scratch with a pipette tip. 12 hours after stimulation of resting microglia or LPS-activated cells with 20 μM of curcumin, migration into the cell-free scratch area was documented. Representative microscopic images clearly showed that curcumin-treated resting cells as well as activated BV-2 cells exhibit a highly reduced migratory potential (Figure [4A](#F4){ref-type="fig"}). The statistical analysis of five independent experiments revealed a significantly reduced number of migrating cells when curcumin was present in the culture medium (Figure [4B](#F4){ref-type="fig"}). As an independent measure of microglial cell motility and to study the long term effects of curcumin, we performed transwell migration assays over a period of 24 hours. Similar as in the scratch assays, the migratory capacity of BV-2 cells was not changed by the activation agent LPS alone (Figure [4C](#F4){ref-type="fig"}). In both, the resting and the activated microglial phenotype, curcumin caused a significant attenuation of microglial migration (Figure [4C](#F4){ref-type="fig"}). These results indicate that curcumin-mediated signaling events have functional consequences related to microglial motility.

![**Curcumin reduces microglial migration**. (A, B) Scratch assays in BV-2 microglia treated with solvent control, 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS for 12 hours. (A) Micrographs from one representative experiment out of five independent experiments are shown. (B) Results of scratch assayss are calculated mean values ± SEM from five independent experiments. (C) Transwell chamber migration of BV-2 microglial cells treated with solvent control, 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS for 24 hours. The absolute number of migrating cells was counted in the lower chamber and mean values ± SEM are displayed. p ≤ 0.05 for curcumin vs. control, and \# p ≤ 0.05 for curcumin + LPS vs. LPS, Student\'s t test.](1742-2094-8-125-4){#F4}

Curcumin inhibits LPS-induced microglial neurotoxicity
------------------------------------------------------

To test whether the transcriptomic changes in curcumin-stimulated cells influence microglial neurotoxicity, 661W photoreceptor cells were incubated with conditioned medium from BV-2 cells. 661W is a retinoblastoma-derived cell line, which represents an established model to study microglial neurotoxicity in the special context of retinal degeneration \[[@B30],[@B31],[@B35]\]. 661W cells were incubated for 48 h with culture supernatants from unstimulated, curcumin-, LPS- or LPS + curcumin-treated BV-2 cells and 661W photoreceptor cell morphology was assessed by phase contrast microscopy. 661W cells in their own medium grew in a spindle-like shape with only few rounded apoptotic cells (Figure [5A](#F5){ref-type="fig"}). Conditioned media from control- or curcumin-treated microglial cells did not affect this morphology (Figure [5A](#F5){ref-type="fig"}). In contrast, 661W cells incubated with LPS-stimulated BV-2 supernatant appeared apoptotic, leading to larger cell-free areas in the culture (Figure [5A](#F5){ref-type="fig"}). When conditioned media from LPS + curcumin-stimulated BV-2 cells was used, a nearly normal 661W cell morphology was retained (Figure [5A](#F5){ref-type="fig"}). Direct incubation of 661W cells with curcumin, LPS, or both had no effects on the cell cultures (data not shown), demonstrating that the observed changes in 661W cell characteristics stem from secreted microglial compounds.

![**Curcumin reduces microglial neurotoxicity on photoreceptors**. (A) Phase contrast micrographs showing morphological changes of 661W photoreceptor cell cultures treated with conditioned media from BV-2 cells for 48 hours. The supernatant from control-stimulated, 20 μM curcumin-treated, 100 ng/ml LPS-treated, or 20 μM curcumin + 100 ng/ml LPS-treated cells was added to 661W photoreceptor cells, respectively. The micrographs shown are from one representative experiment out of three independent experiments with the same tendencies. (B) Apoptosis-related caspase 3/7 activation in 661W photoreceptor cells incubated with conditioned media from control-stimulated, 20 μM curcumin-treated, 100 ng/ml LPS-treated, or 20 μM curcumin + 100 ng/ml LPS-treated BV-2 cells. Results are calculated from three independent experiments performed in duplicate measurements. \* p ≤ 0.05 for LPS vs. control and \# p ≤ 0.05 for curcumin + LPS vs. LPS, respectively, Mann-Whitney Rank Sum test. RLU, relative luciferase units.](1742-2094-8-125-5){#F5}

To corroborate these morphological findings with further functional data, we analyzed the influence of microglia-derived products on caspase-related apoptotic cell death. 661W cells cultured with supernatants from LPS-stimulated BV-2 cells showed a significant induction of caspase 3/7 activity (Figure [5B](#F5){ref-type="fig"}). When using conditioned media from microglial cells co-treated with LPS + curcumin, 661W apoptosis was still present but was significantly diminished (Figure [5B](#F5){ref-type="fig"}). These data clearly implicate that curcumin may limit the production of pro-apoptotic compounds in activated microglial cells or even promote the release of neurotrophic factors.

Discussion
==========

Oxidative stress and neuroinflammation are major factors in the pathogenesis of neurodegenerative disorders \[[@B36]\]. Therefore, antioxidant and anti-inflammatory compounds like curcumin may be treatment options for this group of diseases \[[@B37]\]. However, only few experimental data are available that report on curcumin-triggered transcriptional mechanisms and direct signaling targets in microglia.

Our transcriptomic analysis in BV-2 cells sheds some light on target genes and potential signaling mechanisms. We identified a prominent transcriptional response of resting as well as LPS-activated microglial cells after curcumin treatment. Distinct gene clusters were detected that reflect up-regulated and suppressed transcripts in both microglial phenotypes. We identifed and validated six genes that were constistently induced in resting as well as activated BV-2 cells that have not been described as curcumin targets before. Among these, four curcumin target genes are related to cell migration. Netrin G1 is a lipid-anchored protein that is structurally related to the netrin family of axon guidance molecules \[[@B38]\]. It regulates synaptic interactions between neurons by binding to transmembrane netrin G ligands \[[@B39]\]. Interestingly, the related Netrin 1 molecule is a broad inhibitor of leukocyte chemotaxis \[[@B40]\] and Netrin G1 may have a similar function in microglia. The adhesion molecule PECAM1 is also directly involved in monocyte/macrophage migration \[[@B41]\]. Another migration-related gene induced by curcumin is Plasma cell endoplasmic reticulum protein 1. PERP 1 is a molecular chaperone required for proper folding and secretion of immunoglobulins in B-cells \[[@B42],[@B43]\]. Related to our study, a recent report linked PERP 1 (alias MZB1) to calcium signaling, activation of integrins and cell adhesion \[[@B44]\]. Expression of the Notch-ligand Delta-like 1 has been demonstrated in BV-2 cells and primary rat brain microglial cells, where Notch-1 signaling negatively regulates TNF release \[[@B45]\]. Our data show that basal Dll1 expression in resting microglial cells can be potently induced by curcumin, which could potentially trigger Notch-signaling to prevent migration associated with pro-inflammatory priming of BV-2 cells.

These transcriptomic data of curcumin-treatment promoted us to analyze its effects on microglial motility. Both types of assays, the wound healing assays and the transwell migration experiments, showed that BV-2 cell migration was significantly inhibited by 20 μM curcumin over a period of 12 hours to 24 hours. These findings are in good agreement with papers reporting reduced migration of tumor cells, endothelial cells, and dendritic cells after treatment with comparable doses of cucumin \[[@B46]-[@B48]\]. In the homeostatic state, microglia constantly scan their environment with their long protrusions without movement of the somata \[[@B5]\]. In contrast, migration of microglial cells is a hallmark of pro-inflammatory and chronic activation during early phases of neurodegeneration. Thus, curcumin may support the homeostatic state of microglia and prevent their early and excessive transformation into migrating phagocytes.

It is well known that curcumin broadly inhibits pro-inflammatory gene expression by targeting different signal pathways and transcriptional regulators including NFkB, AP1, EGR1, and STAT3 \[[@B49]\]. Our microarray data corroborate these findings especially in LPS-activated BV-2 cells by showing curcumin-triggered suppression of Ptgs2, Ccl2, Il6, and Nos2, which are NFkB, AP1, and STAT3 target genes \[[@B21]\]. Moreover, the curcumin-regulated transcriptomic profiles revealed lower gene expression of toll-like receptor 2 in resting microglia and complement factor 3 in activated cells. These two factors broadly support the conversion of microglial cells to the pro-inflammatory state \[[@B50],[@B51]\] and hence curcumin signaling may abrogate both pathways. Our data also showed diminished mRNA expression of the transcription factors Egr2 and Stat1 following curcumin-treatment. This indicates that curcumin may further dampen microglial activation by interfering with two other key transcription factors expressed in activated microglial cells. In addition to its inhibitory effects on pro-inflammatory signaling, two well known anti-inflammatory molecules, PPARα and IL4, were significantly induced by curcumin. PPARα and IL4 both specifically inhibit pro-inflammatory activation of microglial cells \[[@B52],[@B53]\] and some of the immune-dampening effects of curcumin may be mediated via this signaling axis.

The cell culture experiments with conditioned media from BV-2 cells showed that curcumin significantly reduced LPS-triggered microglial neurotoxicity on 661W photoreceptor cells. We hypothesize that the strong suppression of LPS-induced Nos2 transcription by curcumin is a major pathway responsible for this phenomenon. In this context, Mandal *et al*. have recently demonstrated that curcumin protects 661W cells from hydrogen peroxide-induced cell death \[[@B29]\]. This effect is very likely mediated by the antioxidant and radical-scavenging capacity of curcumin. In a model of light-induced retinal degeneration, curcumin also suppressed inflammatory marker expression *in vivo*\[[@B29]\], which could be potentially mediated by its attenuating effect on retinal microglia.

Conclusions
===========

We have shown that curcumin triggered global changes in the transcriptome of resting and LPS-activated microglial cells. In addition to its known function in blocking pro-inflammatory gene expression via interference with NFkB signaling, curcumin induced novel anti-inflammatory targets in microglia. Curcumin also significantly inhibited microglial migration and cytotoxicity, which are key features of neuroinflammation. Our publicily avialable dataset provides a basis to understand the pleiotropic beneficial effects of curcumin on microglia as key innate immune cells of the nervous system. Moreover, the results of this study also underscore the importance of curcumin as a promising dietary compound for the treatment of various neurodegenerative disorders associated with inflammation.
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